Twist Stock Valuation

TWST
 Stock
  

USD 35.78  2.01  5.32%   

What would the acquisition value of Twist Bioscience Corp be today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Twist Bioscience, is its stock price multiplied by the total number of shares outstanding, calculating Twist Bioscience's enterprise value requires a different approach. It uses Twist Bioscience's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Twist Bioscience Corp has a current Real Value of $60.51 per share. The regular price of the company is $35.78. At this time, the company appears to be undervalued. Our model measures the value of Twist Bioscience Corp from inspecting the company fundamentals such as Operating Margin of (127.54) %, shares outstanding of 49.63 M, and Return On Equity of (25.38) % as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend acquiring undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
  
Twist Bioscience Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Twist Bioscience's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today 35.78
Please note that Twist Bioscience's price fluctuation is very steady at this time. Calculation of the real value of Twist Bioscience Corp is based on 3 months time horizon. Increasing Twist Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Twist Bioscience Corp is useful when determining the fair value of the Twist stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Twist Bioscience. Since Twist Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Twist Stock. However, Twist Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
60.51
Real Value
66.18
Upside
Estimating the potential upside or downside of Twist Bioscience Corp helps investors to forecast how Twist stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Twist Bioscience more accurately as focusing exclusively on Twist Bioscience's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
31.8938.0444.19
Details
Hype
Prediction
LowEstimated ValueHigh
29.5335.2040.87
Details
Naive
Forecast
LowNext ValueHigh
27.6633.3339.00
Details
4 Analysts
Consensus
LowTarget PriceHigh
100.00136.67200.00
Details

Twist Bioscience Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Twist Bioscience's current stock value. Our valuation model uses many indicators to compare Twist Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Twist Bioscience competition to find correlations between indicators driving Twist Bioscience's intrinsic value. More Info.
Twist Bioscience Corp is currently regarded as top stock in beta category among related companies. It is currently regarded as top stock in price to book category among related companies fabricating about  2.32  of Price to Book per Beta. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Twist Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Twist Bioscience's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Twist Bioscience's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Twist Bioscience's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Twist Bioscience and how it compares across the competition.

About Twist Bioscience Valuation

The stock valuation mechanism determines the current worth of Twist Bioscience Corp on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Twist Bioscience Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Twist Bioscience Corp based exclusively on its fundamental and basic technical indicators. By analyzing Twist Bioscience's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Twist Bioscience's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Twist Bioscience. We calculate exposure to Twist Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Twist Bioscience's related companies.
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California. Twist Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 652 people.

Twist Bioscience Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Twist Bioscience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio7.19
Revenue Growth54.20%
Enterprise Value To Ebitda-10.02
Enterprise Value To Revenue12.06
Additionally, take a look at World Market Map. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for analysis

When running Twist Bioscience Corp price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine Twist Bioscience value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.